Compile Data Set for Download or QSAR
Report error Found 16 Enz. Inhib. hit(s) with all data for entry = 10342
TargetE-selectin(Human)
Glycomimetics.

US Patent
LigandPNGBDBM528667(US11197877, Compound 43)
Affinity DataIC50: 106nMAssay Description:The inhibition assay to screen for and characterize glycomimetic antagonists of E-selectin is a competitive binding assay, which allows the determina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetE-selectin(Human)
Glycomimetics.

US Patent
LigandPNGBDBM528668(US11197877, Compound 44)
Affinity DataIC50: 136nMAssay Description:The inhibition assay to screen for and characterize glycomimetic antagonists of E-selectin is a competitive binding assay, which allows the determina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetE-selectin(Human)
Glycomimetics.

US Patent
LigandPNGBDBM528653(US11197877, Compound 17)
Affinity DataIC50: 150nMAssay Description:The inhibition assay to screen for and characterize glycomimetic antagonists of E-selectin is a competitive binding assay, which allows the determina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetE-selectin(Human)
Glycomimetics.

US Patent
LigandPNGBDBM528655(US11197877, Compound 18)
Affinity DataIC50: 170nMAssay Description:The inhibition assay to screen for and characterize glycomimetic antagonists of E-selectin is a competitive binding assay, which allows the determina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetE-selectin(Human)
Glycomimetics.

US Patent
LigandPNGBDBM528656(US11197877, Compound 24)
Affinity DataIC50: 190nMAssay Description:The inhibition assay to screen for and characterize glycomimetic antagonists of E-selectin is a competitive binding assay, which allows the determina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetE-selectin(Human)
Glycomimetics.

US Patent
LigandPNGBDBM528669(US11197877, Compound 46)
Affinity DataIC50: 192nMAssay Description:The inhibition assay to screen for and characterize glycomimetic antagonists of E-selectin is a competitive binding assay, which allows the determina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetE-selectin(Human)
Glycomimetics.

US Patent
LigandPNGBDBM528659(US11197877, Compound 20 | US20240165139, Compound ...)
Affinity DataIC50: 240nMAssay Description:The inhibition assay to screen for and characterize glycomimetic antagonists of E-selectin is a competitive binding assay, which allows the determina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetE-selectin(Human)
Glycomimetics.

US Patent
LigandPNGBDBM528664(US11197877, Compound 34)
Affinity DataIC50: 340nMAssay Description:The inhibition assay to screen for and characterize glycomimetic antagonists of E-selectin is a competitive binding assay, which allows the determina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetE-selectin(Human)
Glycomimetics.

US Patent
LigandPNGBDBM528665(US11197877, Compound 36)
Affinity DataIC50: 510nMAssay Description:The inhibition assay to screen for and characterize glycomimetic antagonists of E-selectin is a competitive binding assay, which allows the determina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetE-selectin(Human)
Glycomimetics.

US Patent
LigandPNGBDBM528660(US11197877, Compound 21 | US20240165139, Compound ...)
Affinity DataIC50: 520nMAssay Description:The inhibition assay to screen for and characterize glycomimetic antagonists of E-selectin is a competitive binding assay, which allows the determina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetE-selectin(Human)
Glycomimetics.

US Patent
LigandPNGBDBM528658(US11197877, Compound 19)
Affinity DataIC50: 580nMAssay Description:The inhibition assay to screen for and characterize glycomimetic antagonists of E-selectin is a competitive binding assay, which allows the determina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetE-selectin(Human)
Glycomimetics.

US Patent
LigandPNGBDBM528657(US11197877, Compound 25)
Affinity DataIC50: 660nMAssay Description:The inhibition assay to screen for and characterize glycomimetic antagonists of E-selectin is a competitive binding assay, which allows the determina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetE-selectin(Human)
Glycomimetics.

US Patent
LigandPNGBDBM528666(US11197877, Compound 35)
Affinity DataIC50: 720nMAssay Description:The inhibition assay to screen for and characterize glycomimetic antagonists of E-selectin is a competitive binding assay, which allows the determina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetE-selectin(Human)
Glycomimetics.

US Patent
LigandPNGBDBM528663(US11197877, Compound 33 | US20240165139, Compound ...)
Affinity DataIC50: 2.12E+3nMAssay Description:The inhibition assay to screen for and characterize glycomimetic antagonists of E-selectin is a competitive binding assay, which allows the determina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetE-selectin(Human)
Glycomimetics.

US Patent
LigandPNGBDBM528662(US11197877, Compound 31)
Affinity DataIC50: 2.36E+3nMAssay Description:The inhibition assay to screen for and characterize glycomimetic antagonists of E-selectin is a competitive binding assay, which allows the determina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetE-selectin(Human)
Glycomimetics.

US Patent
LigandPNGBDBM528661(US11197877, Compound 30)
Affinity DataIC50: 2.78E+3nMAssay Description:The inhibition assay to screen for and characterize glycomimetic antagonists of E-selectin is a competitive binding assay, which allows the determina...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent